Comparison of methods for the measurement of apoproteins A1 and B in serum
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 22 (5) , 339-344
- https://doi.org/10.1016/s0009-9120(89)80029-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Apolipoprotein A-I containing lipoproteins in coronary artery diseaseAtherosclerosis, 1987
- Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysisAtherosclerosis, 1987
- Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.Heart, 1986
- Apolipoproteins and Coronary Artery DiseaseMayo Clinic Proceedings, 1986
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Some considerations of methodology and standardization of apolipoprotein A-I immunoassays.Clinical Chemistry, 1983
- Some considerations of methodology and standardization of apolipoprotein B immunoassays.Clinical Chemistry, 1983
- Discriminative value of lipids and apoproteins in coronary heart diseaseAtherosclerosis, 1982
- Simultaneous measurement of plasma apolipoproteins A-I and B by electroimmunoassay.Clinical Chemistry, 1982
- Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].Proceedings of the National Academy of Sciences, 1980